{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:14:59Z","timestamp":1791695699842,"version":"4.3.4"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.2967\/jnumed.115.162024","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T22:09:39Z","timestamp":1444342179000},"page":"27-33","source":"Crossref","is-referenced-by-count":405,"title":["Phase I Study of\n                    <sup>68<\/sup>\n                    Ga-HER2-Nanobody for PET\/CT Assessment of HER2 Expression in Breast Carcinoma"],"prefix":"10.2967","volume":"57","author":[{"given":"Marleen","family":"Keyaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Devoogdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Ackaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Vanhoeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois P.","family":"Duhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Schallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vaneycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"De Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lamote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Caveliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lahoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"2021051712083784000_57.1.27.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"2021051712083784000_57.1.27.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.9694"},{"key":"2021051712083784000_57.1.27.3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28710"},{"key":"2021051712083784000_57.1.27.4","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2006.n.025"},{"key":"2021051712083784000_57.1.27.5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1920"},{"key":"2021051712083784000_57.1.27.6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf252"},{"key":"2021051712083784000_57.1.27.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-9931-6"},{"key":"2021051712083784000_57.1.27.8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23051"},{"key":"2021051712083784000_57.1.27.9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fonc.2013.00129","article-title":"Current challenges for HER2 testing in diagnostic pathology: state of the art and controversial issues","volume":"3","author":"Sapino","year":"2013","journal-title":"Front Oncol."},{"key":"2021051712083784000_57.1.27.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602738"},{"key":"2021051712083784000_57.1.27.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2014.08.009"},{"key":"2021051712083784000_57.1.27.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-010-0428-4"},{"key":"2021051712083784000_57.1.27.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2011.06.009"},{"key":"2021051712083784000_57.1.27.14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-180331"},{"key":"2021051712083784000_57.1.27.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.111021"},{"key":"2021051712083784000_57.1.27.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.120600"},{"key":"2021051712083784000_57.1.27.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2298-2"},{"key":"2021051712083784000_57.1.27.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131243"},{"key":"2021051712083784000_57.1.27.19","doi-asserted-by":"publisher","DOI":"10.1002\/cmmi.408"},{"key":"2021051712083784000_57.1.27.20","first-page":"81","article-title":"Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract","volume":"4","author":"Cohen","year":"1989","journal-title":"Oncogene."},{"key":"2021051712083784000_57.1.27.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.073239"},{"key":"2021051712083784000_57.1.27.22","first-page":"664","article-title":"Synthesis and first in vivo evaluation of 18F-anti-HER2-Nanobodies: a new probe for PET imaging of HER2 expression in breast cancer [abstract]","volume":"52","author":"Vaneycken","year":"2011","journal-title":"J Nucl Med."},{"key":"2021051712083784000_57.1.27.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0850-8"},{"key":"2021051712083784000_57.1.27.24","unstructured":"Mattsson S Johansson L Leide Svegborn S . Radiation dose to patients from radiopharmaceuticals: addendum 4 to ICRP publication 53. International Commission on Radiological Protection website. http:\/\/www.icrp.org\/docs\/Radiation Dose to Patients from Radiopharmaceuticals - A fourth addendum to ICRP Publication 53.pdf. Published May 24, 2013. Revised February 24, 2014. Accessed October 20, 2015."},{"key":"2021051712083784000_57.1.27.25","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.12"},{"key":"2021051712083784000_57.1.27.26","doi-asserted-by":"crossref","unstructured":"Gebhart G Lamberts LE Garcia C . PET\/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC) [abstract]. J Clin Oncol. 2014;32(suppl):11001.","DOI":"10.1200\/jco.2014.32.15_suppl.11001"},{"key":"2021051712083784000_57.1.27.27","unstructured":"Keyaerts M, Xavier C, Heemskerk J, et al. First-in-human study of 68GaNOTA-Anti-HER2 Nanobody, a new radiopharmaceutical for positron emission tomography (PET) imaging of HER2 expression in breast carcinoma patients. Presented at: World Molecular Imaging Congress; September 17\u201320, 2014; Seoul, Korea."},{"key":"2021051712083784000_57.1.27.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.122630"},{"key":"2021051712083784000_57.1.27.29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/MNM.0b013e328365d99b","article-title":"Pilot study of 68Ga-DOTA-F(ab\u2032)2-trastuzumab in patients with breast cancer","volume":"34","author":"Beylergil","year":"2013","journal-title":"Nucl Med Commun."},{"key":"2021051712083784000_57.1.27.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.265140"},{"key":"2021051712083784000_57.1.27.31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2994"},{"key":"2021051712083784000_57.1.27.32","doi-asserted-by":"publisher","DOI":"10.7150\/thno.8156"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.115.162024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:06:55Z","timestamp":1621267615000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.115.162024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,4]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.2967\/jnumed.115.162024"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.115.162024","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}